Establish and Apply In Vitro System for Human Cytomegalovirus Capsid Assembly
人巨细胞病毒衣壳组装体外系统的建立和应用
基本信息
- 批准号:8496701
- 负责人:
- 金额:$ 22.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-01 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:Antiviral AgentsAreaBacteriophagesBaculovirusesBindingBinding ProteinsBiochemicalBiologicalBiological AssayBiological ModelsCSNK2A1 geneCapsidCapsid ProteinsCellsCessation of lifeChimera organismComplementCysteineCytomegalovirusDNADNA PackagingDevelopmentEffectivenessElectron MicroscopyFluorescenceFutureGlycogen Synthase Kinase 3HerpesviridaeHerpesvirus 1HousingHumanHuman Herpesvirus 4Human Herpesvirus 8In VitroIndividualInfectionKnowledgeLifeMAP Kinase GeneMethodsMolecularMorbidity - disease rateMutationNatureNuclearNuclear EnvelopeOutcomePathway interactionsPeptide HydrolasesPharmaceutical PreparationsPhosphoproteinsPhosphorylation SitePilot ProjectsPreparationProceduresProcessProteinsReactionRecombinantsRelative (related person)ResearchResearch DesignScaffolding ProteinSedimentation processSeriesSimplexvirusSourceStructureSurfaceSystemSystems DevelopmentTemperatureTestingTherapeuticVirionVirusVirus AssemblyVirus DiseasesWorkbasecell assemblydesignexperienceflexibilitygammaherpesvirushigh throughput screeningmortalitymutantnovelnovel strategiespathogenpreventprotein functionprotein protein interactionprototyperesearch studysarcomascaffoldself assemblysuccess
项目摘要
DESCRIPTION (provided by applicant): We present a plan to establish an in vitro system for studying capsid assembly in the beta-herpesviruses (HCMV). Deficiencies in earlier efforts have been recognized and a strategy to overcome them is developed. There is a need for this system now to answer questions out of reach to more biochemical and biological approaches, and that need is expected to increase as more detailed information is required to develop virus- structure-based therapeutics, and as model systems for herpesvirus tegumentation and DNA packaging evolve. Our research design proceeds methodically from a series of in-cell experiments (Aim 1) that will identify the specific HCMV capsid and capsid-associated proteins required to achieve assembly in recombinant baculovirus-infected cells. As part of those studies, we will investigate the possibility that HCMV capsids require stabilization by a surface-binding protein such as the smallest capsid protein (HCMV pUL48/49), or a putative counterpart of the bacteriophage "cap" protein (HCMV pUL77), or perhaps the tightly capsid-associated basic phosphoprotein (HCMV pUL32), which is without a counterpart among other herpesviruses. We will also establish a cell-free in vitro capsid assembly system for HCMV (Sub-aim 1a), as a complementing and alternate approach to in-cell assembly. We will use the methods pioneered for HSV assembly to guide our work. Not only will an in vitro system substantially increase experimental flexibility, it may prove the most direct and expedient way to identify and overcome shortcomings of the in-cell approach. Recent studies demonstrate the ability of chimeric CMV scaffold proteins to drive assembly of HSV and KSHV capsid shells. In Aim 2, the effect of function-disrupting mutations in the essential HCMV UL80 scaffolding proteins (pUL80.5 and pUL80a) will be tested to assess the suitability of this method as a way to probe the molecular interactions involved in capsid formation. This system allows us to overcome barriers imposed by the essential nature of the scaffolding proteins and the inability to study these functions in HCMV infected cells. The outcome of this R21 proposal will be the development of an in-vitro capsid assembly system for a high-priority human pathogen. The future development of this system to incorporate in-vitro DNA packaging, tegumentation and envelopment of capsids will have significant impact on the development of new and novel antiviral strategies against this virus. HCMV is one of the nine herpesviruses that infect people,
and prototypic of the three human beta-herpesviruses. It causes significant morbidity and mortality, especially in connection with transplacental infections and in immuno-compromised groups. New approaches are needed to prevent and treat infections by this and all herpesviruses, and the assembly system to be developed through this project will aid that endeavor.
描述(由申请人提供):我们提出了一个建立用于研究β-疱疹病毒(HCMV)中衣壳组装的体外系统的计划。已经认识到早期努力的缺陷,并制定了克服这些缺陷的战略。现在需要该系统来回答更多生物化学和生物学方法无法解决的问题,并且随着需要更详细的信息来开发基于病毒结构的治疗剂,以及随着疱疹病毒表皮和DNA包装的模型系统的发展,这种需求预计会增加。 我们的研究设计从一系列的细胞内实验(目的1),将确定特定的HCMV衣壳和衣壳蛋白相关的蛋白质,以实现重组杆状病毒感染的细胞组装有条不紊地进行。作为这些研究的一部分,我们将调查的可能性,HCMV衣壳需要稳定的表面结合蛋白,如最小的衣壳蛋白(HCMV pUL 48/49),或一个假定的对应物的噬菌体“帽”蛋白(HCMV pUL 77),或可能的紧密的衣壳相关的碱性磷蛋白(HCMV pUL 32),这是没有对应物之间的其他疱疹病毒。 我们还将建立一个HCMV的无细胞体外衣壳组装系统(子目标1a),作为细胞内组装的补充和替代方法。我们将使用为HSV组装开创的方法来指导我们的工作。体外系统不仅大大增加了实验的灵活性,而且可能是识别和克服细胞内方法缺点的最直接和最有利的方法。 最近的研究表明嵌合CMV支架蛋白驱动HSV和KSHV衣壳壳组装的能力。在目的2中,将测试基本HCMV UL 80支架蛋白(pUL80.5和pUL 80 a)中功能破坏突变的影响,以评估该方法作为探测衣壳形成中涉及的分子相互作用的方法的适用性。该系统使我们能够克服由支架蛋白的基本性质和无法在HCMV感染的细胞中研究这些功能所施加的障碍。 这项R21提案的结果将是开发一种用于高优先级人类病原体的体外衣壳组装系统。该系统的未来发展,将在体外DNA包装,tegumentation和包装衣壳将有显着的影响,新的和新颖的抗病毒策略的发展,针对这种病毒。 HCMV是感染人类的九种疱疹病毒之一,
也是三种人类β疱疹病毒的原型它引起显著的发病率和死亡率,特别是在与经胎盘感染和免疫功能低下的群体中。需要新的方法来预防和治疗这种和所有疱疹病毒的感染,通过该项目开发的组装系统将有助于这一奋进。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Incorporation of the Kaposi's sarcoma-associated herpesvirus capsid vertex-specific component (CVSC) into self-assembled capsids.
- DOI:10.1016/j.virusres.2017.04.016
- 发表时间:2017-05-15
- 期刊:
- 影响因子:5
- 作者:Grzesik P;MacMath D;Henson B;Prasad S;Joshi P;Desai PJ
- 通讯作者:Desai PJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
D Wade Gibson其他文献
D Wade Gibson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('D Wade Gibson', 18)}}的其他基金
Establish and Apply In Vitro System for Human Cytomegalovirus Capsid Assembly
人巨细胞病毒衣壳组装体外系统的建立和应用
- 批准号:
8385942 - 财政年份:2012
- 资助金额:
$ 22.84万 - 项目类别:
Cytomegalovirus UL80 Proteins:Interactions and Modifications that Impact Function
巨细胞病毒 UL80 蛋白:影响功能的相互作用和修饰
- 批准号:
8191332 - 财政年份:2011
- 资助金额:
$ 22.84万 - 项目类别:
Cytomegalovirus UL80 Proteins:Interactions and Modifications that Impact Function
巨细胞病毒 UL80 蛋白:影响功能的相互作用和修饰
- 批准号:
8263745 - 财政年份:2011
- 资助金额:
$ 22.84万 - 项目类别:
Cytomegalovirus Deubiquitinase pUL48: Identifying Substrate and Inhibitors
巨细胞病毒去泛素酶 pUL48:识别底物和抑制剂
- 批准号:
8105826 - 财政年份:2010
- 资助金额:
$ 22.84万 - 项目类别:
Cytomegalovirus Deubiquitinase pUL48: Identifying Substrate and Inhibitors
巨细胞病毒去泛素酶 pUL48:识别底物和抑制剂
- 批准号:
7642219 - 财政年份:2009
- 资助金额:
$ 22.84万 - 项目类别:
Cytomegalovirus Deubiquitinase pUL48: Identifying Substrate and Inhibitors
巨细胞病毒去泛素酶 pUL48:识别底物和抑制剂
- 批准号:
7762204 - 财政年份:2009
- 资助金额:
$ 22.84万 - 项目类别:
HERPESVIRUS PROTEINASE--POSSIBLE TARGET FOR ANTIVIRALS
疱疹病毒蛋白酶——抗病毒药物的可能靶标
- 批准号:
6170156 - 财政年份:1992
- 资助金额:
$ 22.84万 - 项目类别:
Herpesvirus Proteinase - Possible Target for Antivirals
疱疹病毒蛋白酶——抗病毒药物的可能靶点
- 批准号:
7156940 - 财政年份:1992
- 资助金额:
$ 22.84万 - 项目类别:
HERPESVIRUS PROTEINASE--POSSIBLE TARGET FOR ANTIVIRAL
疱疹病毒蛋白酶——抗病毒的可能靶点
- 批准号:
3148046 - 财政年份:1992
- 资助金额:
$ 22.84万 - 项目类别:
HERPESVIRUS PROTEINASE--POSSIBLE TARGET FOR ANTIVIRALS
疱疹病毒蛋白酶——抗病毒药物的可能靶标
- 批准号:
2003823 - 财政年份:1992
- 资助金额:
$ 22.84万 - 项目类别:
相似国自然基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
- 批准号:2021JJ40433
- 批准年份:2021
- 资助金额:0.0 万元
- 项目类别:省市级项目
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
- 批准号:32001603
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
AREA国际经济模型的移植.改进和应用
- 批准号:18870435
- 批准年份:1988
- 资助金额:2.0 万元
- 项目类别:面上项目
相似海外基金
Onboarding Rural Area Mathematics and Physical Science Scholars
农村地区数学和物理科学学者的入职
- 批准号:
2322614 - 财政年份:2024
- 资助金额:
$ 22.84万 - 项目类别:
Standard Grant
Point-scanning confocal with area detector
点扫描共焦与区域检测器
- 批准号:
534092360 - 财政年份:2024
- 资助金额:
$ 22.84万 - 项目类别:
Major Research Instrumentation
TRACK-UK: Synthesized Census and Small Area Statistics for Transport and Energy
TRACK-UK:交通和能源综合人口普查和小区域统计
- 批准号:
ES/Z50290X/1 - 财政年份:2024
- 资助金额:
$ 22.84万 - 项目类别:
Research Grant
Wide-area low-cost sustainable ocean temperature and velocity structure extraction using distributed fibre optic sensing within legacy seafloor cables
使用传统海底电缆中的分布式光纤传感进行广域低成本可持续海洋温度和速度结构提取
- 批准号:
NE/Y003365/1 - 财政年份:2024
- 资助金额:
$ 22.84万 - 项目类别:
Research Grant
Collaborative Research: Scalable Manufacturing of Large-Area Thin Films of Metal-Organic Frameworks for Separations Applications
合作研究:用于分离应用的大面积金属有机框架薄膜的可扩展制造
- 批准号:
2326714 - 财政年份:2024
- 资助金额:
$ 22.84万 - 项目类别:
Standard Grant
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427233 - 财政年份:2024
- 资助金额:
$ 22.84万 - 项目类别:
Standard Grant
Collaborative Research: Scalable Manufacturing of Large-Area Thin Films of Metal-Organic Frameworks for Separations Applications
合作研究:用于分离应用的大面积金属有机框架薄膜的可扩展制造
- 批准号:
2326713 - 财政年份:2024
- 资助金额:
$ 22.84万 - 项目类别:
Standard Grant
Unlicensed Low-Power Wide Area Networks for Location-based Services
用于基于位置的服务的免许可低功耗广域网
- 批准号:
24K20765 - 财政年份:2024
- 资助金额:
$ 22.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427232 - 财政年份:2024
- 资助金额:
$ 22.84万 - 项目类别:
Standard Grant
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427231 - 财政年份:2024
- 资助金额:
$ 22.84万 - 项目类别:
Standard Grant